Thu, October 22, 2020

Matthew Taylor Maintained (ABT) at Strong Buy with Increased Target to $122 on, Oct 22nd, 2020

Matthew Taylor of UBS, Maintained "Abbott Laboratories" (ABT) at Strong Buy with Increased Target from $119 to $122 on, Oct 22nd, 2020.

Matthew has made no other calls on ABT in the last 4 months.



There are 8 other peers that have a rating on ABT. Out of the 8 peers that are also analyzing ABT, 0 agree with Matthew's Rating of Hold.



These are the ratings of the 8 analyists that currently disagree with Matthew


  • Rick Wise of "Stifel" Maintained at Strong Buy with Increased Target to $120 on, Wednesday, October 21st, 2020
  • Joshua Jennings of "TD Cowen" Maintained at Buy with Decreased Target to $113 on, Monday, October 19th, 2020
  • Robbie Marcus of "JP Morgan" Maintained at Buy with Increased Target to $125 on, Friday, October 9th, 2020
  • Mike Polark of "Wolfe Research" Initiated at Buy and Held Target at $124 on, Friday, September 11th, 2020
  • Joanne Wuensch of "Citigroup" Maintained at Strong Buy with Increased Target to $130 on, Friday, August 28th, 2020
  • Larry Biegelsen of "Wells Fargo" Maintained at Buy with Increased Target to $115 on, Thursday, August 27th, 2020
  • David Toung of "Argus Research" Maintained at Strong Buy with Increased Target to $125 on, Thursday, July 23rd, 2020
  • John Sourbeer of "UBS" Maintained at Strong Buy with Increased Target to $110 on, Friday, July 17th, 2020